In Vitro Diagnostic Industry in China - POCT IX

1.2 Cardiovascular Diseases (Cardiac Markers)

Cardiovascular disease remains the leading cause of death worldwide. More than half a billion people around the world continue to be affected by cardiovascular diseases, which accounted for 20.5 million deaths in 2021 – close to a third of all deaths globally and an overall increase on the estimated 121 million CVD deaths. More importantly, many cardiovascular events are not fatal but may be sufficient to reduce body function and seriously affect the quality of life. The global cardiac biomarker POCT market, valued at $2.8 billion in 2023, is projected to grow at 8.3% CAGR through 2030, driven by aging populations.

1.3 Infectious Diseases

The global infectious disease point-of-care (POC) testing market was valued at around $3.3 billion in 2023. The increasing global burden of infectious diseases is a key driver of growth in the point-of-care (POC) infectious disease testing market. With the emergence of new infectious pathogens, the re-emergence of previously controlled diseases, and the growing threat of antimicrobial resistance, rapid and accurate diagnostics are critical for timely intervention. Diseases such as HIV, hepatitis, influenza, and tuberculosis continue to affect millions worldwide.

Last: In Vitro Diagnostic Industry in China - POCT VIII